Nureca [NURECA] vs Fischer Medical [FISCHER] Detailed Stock Comparison

Nureca Ltd.

NSE
Loading...

Fischer Medical Ventures Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Nureca Ltd. wins in 12 metrics, Fischer Medical Ventures Ltd. wins in 7 metrics, with 0 ties. Nureca Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Nureca Ltd. Fischer Medical Ventures Ltd. Better
P/E Ratio (TTM) 24.00 63.39 Nureca Ltd.
Price-to-Book Ratio 1.54 6.72 Nureca Ltd.
Debt-to-Equity Ratio 2.71 10.26 Nureca Ltd.
PEG Ratio -0.03 0.13 Fischer Medical Ventures Ltd.
EV/EBITDA 42.40 57.80 Nureca Ltd.
Profit Margin (TTM) 7.43% 15.17% Fischer Medical Ventures Ltd.
Operating Margin (TTM) 6.94% 20.57% Fischer Medical Ventures Ltd.
EBITDA Margin (TTM) 6.94% 20.57% Fischer Medical Ventures Ltd.
Return on Equity 0.44% 0.36% Nureca Ltd.
Return on Assets (TTM) 0.40% 0.26% Nureca Ltd.
Free Cash Flow (TTM) $-234.06M $-927.26M Nureca Ltd.
1-Year Return -17.00% -57.40% Nureca Ltd.
Price-to-Sales Ratio (TTM) 1.85 9.41 Nureca Ltd.
Enterprise Value $2.54B $24.93B Fischer Medical Ventures Ltd.
EV/Revenue Ratio 1.78 9.59 Nureca Ltd.
Gross Profit Margin (TTM) 36.32% 50.38% Fischer Medical Ventures Ltd.
Revenue per Share (TTM) $148 $3 Nureca Ltd.
Earnings per Share (Diluted) $11.04 $0.59 Nureca Ltd.
Beta (Stock Volatility) 0.61 -0.03 Fischer Medical Ventures Ltd.

Nureca Ltd. vs Fischer Medical Ventures Ltd. Stock Performance Analysis

Loading Price Chart...

NURECA
FISCHER

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Nureca Ltd.1.53%2.79%-13.68%-4.29%-16.61%-24.18%
Fischer Medical Ventures Ltd.-1.55%10.75%2.12%7.06%-21.38%-14.16%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Nureca Ltd.-17.00%-36.56%-85.03%-65.77%-65.77%-65.77%
Fischer Medical Ventures Ltd.-57.40%-70.45%1,348.00%-12.14%101.56%439.49%

Performance & Financial Health Analysis: Nureca Ltd. vs Fischer Medical Ventures Ltd.

MetricNURECAFISCHER
Market Information
Market Cap i₹2.67B₹24.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i9,10971,158
90 Day Avg. Volume i14,978126,154
Last Close₹235.65₹35.64
52 Week Range₹204.00 - ₹343.00₹31.13 - ₹124.20
% from 52W High-31.30%-71.30%
All-Time High₹2,315.00 (Oct 04, 2021)₹2,386.00 (Apr 21, 2008)
% from All-Time High-89.82%-98.51%
Growth Metrics
Quarterly Revenue Growth0.50%7.61%
Quarterly Earnings Growth0.27%N/A
Financial Health
Profit Margin (TTM) i0.07%0.15%
Operating Margin (TTM) i0.07%0.21%
Return on Equity (TTM) i0.00%0.00%
Debt to Equity (MRQ) i2.7110.26
Cash & Liquidity
Book Value per Share (MRQ)₹172.08₹5.57
Cash per Share (MRQ)₹9.15₹0.67
Operating Cash Flow (TTM) i₹-172,050,000₹-1,015,668,000
Levered Free Cash Flow (TTM) i₹8.46M₹12.08M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Nureca Ltd. vs Fischer Medical Ventures Ltd.

MetricNURECA (Apr 24, 2026)FISCHER (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i24.0063.39
Forward P/E iN/AN/A
PEG Ratio i-0.030.13
Price to Sales (TTM) i1.859.41
Price to Book (MRQ) i1.546.72
Market Capitalization
Market Capitalization i₹2.67B₹24.43B
Enterprise Value i₹2.54B₹24.93B
Enterprise Value Metrics
Enterprise to Revenue i1.789.59
Enterprise to EBITDA i42.4057.80
Risk & Other Metrics
Beta i0.61-0.03
Book Value per Share (MRQ) i₹172.08₹5.57

Financial Statements Comparison: Nureca Ltd. vs Fischer Medical Ventures Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNURECA (2025)FISCHER (2025)
Revenue/Sales i1.10B1.11B
Cost of Goods Sold i687.02M915.90M
COGS % of Revenue i62.6%82.7%
Gross Profit i409.59M191.09M
Gross Margin i37.4%17.3%
Research & Development iN/AN/A
Operating Income (EBIT) i-98.28M30.61M
Operating Margin i-9.0%2.8%
EBITDA i620,00053.47M
EBITDA Margin i0.1%4.8%
Pre-Tax Income i13.43M22.23M
Pre-Tax Income % of Revenue i1.2%2.0%
Income Tax i4.97M10.15M
Income Tax % of Revenue i0.5%0.9%
Net Income (Profit) i8.46M12.08M
Profit Margin i0.8%1.1%

Balance Sheet & Liquidity Metrics

MetricNURECA (2025)FISCHER (2025)
Cash & Equivalents i32.41M1.04B
Total Current Assets i1.90B3.65B
Total Current Assets % of Revenue i173.2%330.0%
Total Current Liabilities i123.99M1.02B
Total Current Liabilities % of Revenue i11.3%92.0%
Long-Term Debt i25.90M172.06M
Long-Term Debt % of Revenue i2.4%15.5%
Total Shareholders Equity i1.94B3.38B
Retained Earnings i868.20M29.05M
Retained Earnings % of Revenue i79.2%2.6%
Property, Plant & Equipment i70.13M89.03M

Cash Flow Statement Comparison

MetricNURECA (2025)FISCHER (2025)
Operating Cash Flow i-172.05M-1.02B
Operating Cash Flow % of Revenue i-15.7%-91.8%
Capital Expenditures i-42.94M-59.87M
Free Cash Flow i-234.06M-927.26M
FCF Margin i-21.3%-83.8%
Debt Repayment i-1.96MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNURECAFISCHER
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i9.54M654.52M
Float Shares i2.75M164.93M
% Held by Insiders i68.13%76.28%
% Held by Institutions i0.00%2.54%
% Held by Public i31.87%21.18%

Dividend Analysis & Yield Comparison: Nureca Ltd. vs Fischer Medical Ventures Ltd.

MetricNURECAFISCHER
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A